{"pmid":32474092,"title":"COVID-19 associated encephalopathies and cerebrovascular disease: the New Orleans experience.","text":["COVID-19 associated encephalopathies and cerebrovascular disease: the New Orleans experience.","World Neurosurg","Scullen, Tyler","Keen, Joseph","Mathkour, Mansour","Dumont, Aaron S","Kahn, Lora","32474092"],"journal":"World Neurosurg","authors":["Scullen, Tyler","Keen, Joseph","Mathkour, Mansour","Dumont, Aaron S","Kahn, Lora"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474092","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.wneu.2020.05.192","keywords":["infectious disease","sar-cov-2","cerebrovascular disease","neurological surgery"],"locations":["New Orleans"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1668341932715147265,"score":9.490897,"similar":[{"pmid":32380334,"pmcid":"PMC7198391","title":"Impact of the COVID-19 Pandemic on Neurosurgical Residency Training in New Orleans.","text":["Impact of the COVID-19 Pandemic on Neurosurgical Residency Training in New Orleans.","World Neurosurg","Scullen, Tyler","Mathkour, Mansour","Maulucci, Christopher M","Dumont, Aaron S","Bui, Cuong J","Keen, Joseph R","32380334"],"journal":"World Neurosurg","authors":["Scullen, Tyler","Mathkour, Mansour","Maulucci, Christopher M","Dumont, Aaron S","Bui, Cuong J","Keen, Joseph R"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32380334","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.wneu.2020.04.208","keywords":["covid-19","education","neurological surgery","new orleans","pandemic"],"locations":["New Orleans"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666597097366880257,"score":65.4922},{"pmid":32310015,"title":"Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature.","text":["Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature.","INTRODUCTION: There is an urgent need to identify patients at high risk during the ongoing coronavirus disease (COVID-19) pandemic. Whether a history of stroke is associated with increased severity of disease or mortality is unknown. METHOD: We pooled studies from published literature to assess the association of a history of stroke with outcomes in patients with COVID-19. RESULTS: A pooled analysis of 4 studies showed a approximately 2.5-fold increase in odds of severe COVID-19. While a trend was observed, there was no statistically significant association of stroke with mortality in patients with COVID-19 infection. DISCUSSION: Our findings are limited by a small number of studies and sample size. CONCLUSION: There is a approximately 2.5-fold increase in odds of severe COVID-19 illness with a history of cerebrovascular disease.","Int J Stroke","Aggarwal, Gaurav","Lippi, Giuseppe","Michael Henry, Brandon","32310015"],"abstract":["INTRODUCTION: There is an urgent need to identify patients at high risk during the ongoing coronavirus disease (COVID-19) pandemic. Whether a history of stroke is associated with increased severity of disease or mortality is unknown. METHOD: We pooled studies from published literature to assess the association of a history of stroke with outcomes in patients with COVID-19. RESULTS: A pooled analysis of 4 studies showed a approximately 2.5-fold increase in odds of severe COVID-19. While a trend was observed, there was no statistically significant association of stroke with mortality in patients with COVID-19 infection. DISCUSSION: Our findings are limited by a small number of studies and sample size. CONCLUSION: There is a approximately 2.5-fold increase in odds of severe COVID-19 illness with a history of cerebrovascular disease."],"journal":"Int J Stroke","authors":["Aggarwal, Gaurav","Lippi, Giuseppe","Michael Henry, Brandon"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32310015","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1177/1747493020921664","keywords":["covid-19","cerebrovascular disease","coronavirus"],"topics":["Diagnosis"],"weight":1,"_version_":1666138491210170368,"score":54.198956},{"pmid":32409316,"title":"Cerebrovascular Disease in COVID-19.","text":["Cerebrovascular Disease in COVID-19.","Coronavirus disease 19 (COVID-19) is a pandemic originating in Wuhan, China, in December 2019. Early reports suggest that there are neurologic manifestations of COVID-19, including acute cerebrovascular disease. We report a case of COVID-19 with acute ischemic stroke. To our knowledge, this is the first reported case of COVID-19-related cerebral infarcts that includes brain imaging at multiple time points and CT angiography. There is a growing body of published evidence that complications of COVID-19 are not limited to the pulmonary system. Neuroradiologists should be aware of a wide range of neurologic manifestations, including cerebrovascular disease.","AJNR Am J Neuroradiol","Goldberg, Michael F","Goldberg, Morton F","Cerejo, R","Tayal, A H","32409316"],"abstract":["Coronavirus disease 19 (COVID-19) is a pandemic originating in Wuhan, China, in December 2019. Early reports suggest that there are neurologic manifestations of COVID-19, including acute cerebrovascular disease. We report a case of COVID-19 with acute ischemic stroke. To our knowledge, this is the first reported case of COVID-19-related cerebral infarcts that includes brain imaging at multiple time points and CT angiography. There is a growing body of published evidence that complications of COVID-19 are not limited to the pulmonary system. Neuroradiologists should be aware of a wide range of neurologic manifestations, including cerebrovascular disease."],"journal":"AJNR Am J Neuroradiol","authors":["Goldberg, Michael F","Goldberg, Morton F","Cerejo, R","Tayal, A H"],"date":"2020-05-16T11:00:00Z","year":2020,"_id":"32409316","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3174/ajnr.A6588","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666897319150223360,"score":44.672607},{"pmid":32425321,"pmcid":"PMC7229718","title":"Neurologic complications of COVID-19.","text":["Neurologic complications of COVID-19.","Background: Much of the focus regarding the global pandemic of coronavirus disease of 2019 (COVID-19) has been on the cardiovascular, pulmonary, and hematologic complications. However, neurologic complications have arisen as an increasingly recognized area of morbidity and mortality. Objective: This brief report summarizes the neurologic complications associated with COVID-19 with an emphasis on the emergency medicine clinician. Discussion: COVID-19 has infected over 3.5 million people and killed over 240,000 people worldwide. While pulmonary complications are profound, the neurologic system is also significantly impacted, with complications including acute cerebrovascular events, encephalitis, Guillain-Barre syndrome, acute necrotizing hemorrhagic encephalopathy, and hemophagocytic lymphohistiocytosis. Additionally, patients on immunosuppressive medications for pre-existing neurologic issues are at an increased risk for complications with COVID-19 infection, and many of the currently proposed COVID-19 therapies can interact with these medications. Conclusions: When caring for COVID-19 patients, emergency medicine clinicians should be aware of the neurologic complications from COVID-19.","Am J Emerg Med","Bridwell, Rachel","Long, Brit","Gottlieb, Michael","32425321"],"abstract":["Background: Much of the focus regarding the global pandemic of coronavirus disease of 2019 (COVID-19) has been on the cardiovascular, pulmonary, and hematologic complications. However, neurologic complications have arisen as an increasingly recognized area of morbidity and mortality. Objective: This brief report summarizes the neurologic complications associated with COVID-19 with an emphasis on the emergency medicine clinician. Discussion: COVID-19 has infected over 3.5 million people and killed over 240,000 people worldwide. While pulmonary complications are profound, the neurologic system is also significantly impacted, with complications including acute cerebrovascular events, encephalitis, Guillain-Barre syndrome, acute necrotizing hemorrhagic encephalopathy, and hemophagocytic lymphohistiocytosis. Additionally, patients on immunosuppressive medications for pre-existing neurologic issues are at an increased risk for complications with COVID-19 infection, and many of the currently proposed COVID-19 therapies can interact with these medications. Conclusions: When caring for COVID-19 patients, emergency medicine clinicians should be aware of the neurologic complications from COVID-19."],"journal":"Am J Emerg Med","authors":["Bridwell, Rachel","Long, Brit","Gottlieb, Michael"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32425321","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ajem.2020.05.024","keywords":["covid-19","cerebrovascular disease","coronavirus","encephalopathy","hlh","infectious disease","neurologic"],"topics":["Treatment"],"weight":1,"_version_":1667352728838340609,"score":43.477448},{"pmid":32330267,"pmcid":"PMC7188122","title":"Pulmonary embolism in returning traveler with COVID-19 pneumonia.","text":["Pulmonary embolism in returning traveler with COVID-19 pneumonia.","J Travel Med","Foch, Emilie","Allou, Nathalie","Vitry, Thierry","Masse, Laurie","Allyn, Jerome","Andre, Michel","Allou, Nicolas","32330267"],"journal":"J Travel Med","authors":["Foch, Emilie","Allou, Nathalie","Vitry, Thierry","Masse, Laurie","Allyn, Jerome","Andre, Michel","Allou, Nicolas"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330267","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1093/jtm/taaa063","keywords":["acute pulmonary embolism; traveler","covid-19","sar-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1666138494550933504,"score":42.33699}]}